UK biotech funding shows early recovery after mid-2025 lull, BIA reports
read at Endpoints ↗Positive
The BioIndustry Association released data indicating that equity financing for UK biotech companies is beginning to rise again in early 2026.
The trend follows a slowdown that began in mid-2025, when investment levels fell across the sector.
In the first quarter of 2026, total equity funding showed an increase compared with the previous quarter, suggesting renewed investor interest.
The BIA said the uptick could signal a broader revival of the UK biotech ecosystem, though it cautioned that sustained growth will depend on continued market confidence.
source
This writeup was produced by pharmadog from original reporting by Endpoints.
Original headline: “Investment in UK biotechs shows early signs of recovery, report says”
read at Endpoints ↗82 words · retrieved Apr 27
comments(0)
5-min edit window · permanent after that